dopamine dysregulation syndrome dds dysfunction reward system observed individuals taking dopaminergic medications extended length time typically occurs people parkinsons disease pd taken dopamine agonist medications extended period time characterized problems addiction medication gambling sexual common symptom craving dopaminergic medication however behavioral symptoms appear independently craving cooccur craving intense impulse subject obtain medication even absence symptoms indicate fulfill need person selfadminister extra doses selfadministration possible aggressive outbursts use strategies symptom simulation bribery access additional medication also hypomania manifesting feelings euphoria omnipotence grandiosity prone appear moments medication effects maximum dysphoria characterized sadness psychomotor slowing fatigue apathy typical dopamine replacement therapy drt different impulse control disorders described including gambling compulsive shopping eating disorders behavioral disturbances commonly aggressive tendencies norm psychosis also parkinsons disease common neurological disorder characterized degeneration dopamine neurons substantia nigra loss dopamine putamen described motor disease also produces cognitive behavioral symptoms common treatment dopamine replacement therapy consists administration levodopa ldopa dopamine agonists pramipexole ropinirole patients dopamine replacement therapy well known improve motor symptoms effects cognitive behavioral symptoms dopamine related normal learning stimuli behavioral motivational significance attention importantly reward accordance role dopamine reward processing addictive drugs stimulate dopamine although exact mechanism yet elucidated role dopamine reward system addiction proposed origin models addiction used explain dopamine replacement therapy produces one models addiction proposes usage course drug habituation rewarding effects produces initial stages habituation thought dopamine mediated longterm administration ldopa reward system gets used needs higher quantities user increases drug intake loss dopaminergic receptors striatum acts addition impairment goaldirection mental functions produce enhancement sensitization dopamine therapy behavioral mood symptoms syndrome produced dopamine diagnosis syndrome clinical since laboratory tests confirm diagnosis person documented responsiveness medication increase medication intake beyond dosage needed relieve parkinsonian symptoms pathological addictionlike pattern current mood disorder depression anxiety hypomanic state euphoria behavioral disorder excessive gambling shopping sexual tendency aggression social isolation altered perception effect medication also questionnaire typical symptoms dds also developed help diagnosis main prevention measure proposed prescription lowest possible dose dopamine replacement therapy individuals minimization use dopamine agonists short duration formulations ldopa also decrease risk first choice management measure consists enforcement dopaminergic drug dosage reduction decrease maintained dysregulation syndrome features soon cessation dopamine agonists therapy may also behavioral characteristics may respond psychotherapy social support important control risk factors cases antipsychotic drugs may also use presence psychosis aggression gambling based upon five case valproic acid may efficacy controlling symptoms levodopainduced dds arise use levodopa treatment parkinsons dds common among pd patients prevalence may around prevalence higher among males early onset previous substance abuse heavy drinking drug intake seems main risk factor along history affective pd first formally described however ldopa enter clinical practice almost initial works already reports neuropsychiatric following decades cases featuring dds symptoms relation dopamine therapy hypersexuality gambling punding dds first described syndrome year three years later first review articles syndrome written showing increasing awareness dds diagnostic criteria proposed httpsenwikipediaorgwikidopaminedysregulationsyndrome